🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Shih Lin Goh

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0001-9942-2331
Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicinePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs).

45 citations

Winnie Ngo, Min Xu, Shih Lin Goh, Silveria Rodriguez, Ming-Tain Lai +3 more

1 citations

Gregory C. Adam, John A. Howe, Vijeta Sharma, Matthew Zimmerman, Enriko Dolgov +26 more

31 citations

Livio Azzoni, Brian N. Ross, Matthew Fair, Zhe Yuan, Kwasi Gyampoh +20 more

38 citations

Hyun Jae Yu, Cindy Buffone, Szu‐Wei Huang, Kyeongeun Lee, Shih Lin Goh +7 more

5 citations

Gregory C. Adam, John A. Howe, Vijeta Sharma, Matthew Zimmerman, Enriko Dolgov +26 more